FdaApplication
ANDA 205994
Identifiers
- fda_app_no: ANDA205994
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2023-07-31 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SAXAGLIPTIN | SAXAGLIPTIN HYDROCHLORIDE | EQ 5MG BASE | TABLET;ORAL |
| SAXAGLIPTIN | SAXAGLIPTIN HYDROCHLORIDE | EQ 2.5MG BASE | TABLET;ORAL |
2 products